Literature DB >> 21150123

Unique sugar metabolic pathways of bifidobacteria.

Shinya Fushinobu1.   

Abstract

Bifidobacteria have many beneficial effects for human health. The gastrointestinal tract, where natural colonization of bifidobacteria occurs, is an environment poor in nutrition and oxygen. Therefore, bifidobacteria have many unique glycosidases, transporters, and metabolic enzymes for sugar fermentation to utilize diverse carbohydrates that are not absorbed by host humans and animals. They have a unique, effective central fermentative pathway called bifid shunt. Recently, a novel metabolic pathway that utilizes both human milk oligosaccharides and host glycoconjugates was found. The galacto-N-biose/lacto-N-biose I metabolic pathway plays a key role in colonization in the infant gastrointestinal tract. These pathways involve many unique enzymes and proteins. This review focuses on their molecular mechanisms, as revealed by biochemical and crystallographic studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21150123     DOI: 10.1271/bbb.100494

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  34 in total

1.  A Human Gut Commensal Ferments Cranberry Carbohydrates To Produce Formate.

Authors:  Ezgi Özcan; Jiadong Sun; David C Rowley; David A Sela
Journal:  Appl Environ Microbiol       Date:  2017-08-17       Impact factor: 4.792

2.  Unraveling the Leloir pathway of Bifidobacterium bifidum: significance of the uridylyltransferases.

Authors:  Frederik De Bruyn; Joeri Beauprez; Jo Maertens; Wim Soetaert; Marjan De Mey
Journal:  Appl Environ Microbiol       Date:  2013-09-06       Impact factor: 4.792

3.  Characterization of a novel β-L-Arabinofuranosidase in Bifidobacterium longum: functional elucidation of A DUF1680 family member.

Authors:  Kiyotaka Fujita; Yukari Takashi; Eriko Obuchi; Kanefumi Kitahara; Toshihiko Suganuma
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

4.  Characterization of a novel β-L-arabinofuranosidase in Bifidobacterium longum: functional elucidation of a DUF1680 protein family member.

Authors:  Kiyotaka Fujita; Yukari Takashi; Eriko Obuchi; Kanefumi Kitahara; Toshihiko Suganuma
Journal:  J Biol Chem       Date:  2014-01-02       Impact factor: 5.157

5.  Prebiotic Oligosaccharides: Comparative Evaluation Using In Vitro Cultures of Infants' Fecal Microbiomes.

Authors:  J Stiverson; T Williams; J Chen; S Adams; D Hustead; P Price; J Guerrieri; J Deacon; Z Yu
Journal:  Appl Environ Microbiol       Date:  2014-09-19       Impact factor: 4.792

6.  Pareto Optimality Explanation of the Glycolytic Alternatives in Nature.

Authors:  Chiam Yu Ng; Lin Wang; Anupam Chowdhury; Costas D Maranas
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

7.  α-N-acetylgalactosaminidase from infant-associated bifidobacteria belonging to novel glycoside hydrolase family 129 is implicated in alternative mucin degradation pathway.

Authors:  Masashi Kiyohara; Takashi Nakatomi; Shin Kurihara; Shinya Fushinobu; Hideyuki Suzuki; Tomonari Tanaka; Shin-Ichiro Shoda; Motomitsu Kitaoka; Takane Katayama; Kenji Yamamoto; Hisashi Ashida
Journal:  J Biol Chem       Date:  2011-11-16       Impact factor: 5.157

8.  Crystal structures of a glycoside hydrolase family 20 lacto-N-biosidase from Bifidobacterium bifidum.

Authors:  Tasuku Ito; Takane Katayama; Mitchell Hattie; Haruko Sakurama; Jun Wada; Ryuichiro Suzuki; Hisashi Ashida; Takayoshi Wakagi; Kenji Yamamoto; Keith A Stubbs; Shinya Fushinobu
Journal:  J Biol Chem       Date:  2013-03-11       Impact factor: 5.157

9.  Utilization of galactooligosaccharides by Bifidobacterium longum subsp. infantis isolates.

Authors:  Daniel Garrido; Santiago Ruiz-Moyano; Rogelio Jimenez-Espinoza; Hyun-Ju Eom; David E Block; David A Mills
Journal:  Food Microbiol       Date:  2012-10-22       Impact factor: 5.516

Review 10.  Bifidobacterial enzymes involved in the metabolism of human milk oligosaccharides.

Authors:  Motomitsu Kitaoka
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.